Background: Respiratory syncytial virus (RSV) infects nearly all infants by age 2 and is a leading cause of bronchiolitis. RSV may employ several mechanisms to induce immune dysregulation, including dendritic cell (DC) modulation during the immune response to RSV.
Methods And Findings: Expansion of cDC and pDC by Flt3L treatment promoted an anti-viral response with reduced pathophysiology characterized by decreased airway hyperreactivity, reduced Th2 cytokines, increased Th1 cytokines, and a reduction in airway inflammation and mucus overexpression. These protective aspects of DC expansion could be completely reversed by depleting pDCs during the RSV infection. Expansion of DCs by Flt3L treatment enhanced in CD8+ T cell responses, which was reversed by depletion of pDC.
Conclusions: These results indicate that a balance between cDC and pDC in the lung and its lymph nodes is crucial for the outcome of a pulmonary infection. Increased pDC numbers induced by Flt3L treatment have a protective impact on the nature of the overall immune environment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249704 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001720 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Microwave Ablation Combined with Flt3L Provokes Tumor-Specific Memory CD8 T Cells-Mediated Antitumor Immunity in Response to PD-1 Blockade.
Adv Sci (Weinh)
December 2024
Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities, Shandong Lung Cancer Institute, 16766 Jingshi Road, Jinan, 250014, P. R. China.
For medically inoperable non-small cell lung cancer, microwave ablation (MWA) represents a super minimally invasive alternative treatment. However, tumor recurrence remains a concern. Here, it is demonstrated that the combination of MWA with Flt3L significantly inhibits tumor recurrence by CD8 central memory T (T)-like cell-dependent antitumor immune responses within the tumor-draining lymph nodes (TdLN).
View Article and Find Full Text PDFHuman dendritic cell differentiation in hematopoietic stem cell-transplanted NOG hFLT3L Tg/mFlt3 KO humanized mice.
Immunol Lett
December 2024
Central Institute for Experimental Medicine and Life Science, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. Electronic address:
Article Synopsis
- Humanized mice created by transferring human stem cells into a specific type of NOG mouse develop mature human lymphoid cells, but struggle to produce fully differentiated human dendritic cells (DCs), which are vital for T cell activation.
- Researchers engineered a new mouse model (hFLT3L-Tg) to promote human DC development, but encountered issues with low human cell engraftment due to interference from mouse myeloid cells caused by receptor cross-reactivity.
- To resolve this, they utilized CRISPR technology to create a mouse model (FL Tg/KO) that blocks this interference, allowing for successful human cell engraftment and differentiation of various human DC types, making it a promising tool for studying human immune responses
Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity.
Gene Ther
October 2024
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Dendritic cells (DCs) constitute a distinct type of immune cell found within tumors, serving a central role in mediating tumor antigen-specific immunity against cancer cells. Frequently, DC functions are dysregulated by the immunosuppressive signals present within the tumor microenvironment (TME). Consequently, DC manipulation holds great potential to enhance the cytotoxic T cell response against cancer diseases.
View Article and Find Full Text PDFDendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy.
J Immunother Cancer
October 2024
Pathology and Medicine, The University of Chicago Biological Sciences Division, Chicago, Illinois, USA
Background: Individuals with a loss-of-function single-nucleotide polymorphism in the gene encoding PTPN22 have an increased risk for autoimmune diseases, and patients with cancer with such alleles may respond better to checkpoint blockade immunotherapy. Studies in PTPN22 knockout (KO) mice have established it as a negative regulator of T cell responses in cancer models. However, the role of PTPN22 in distinct immune cell compartments, such as dendritic cells (DCs), remains undefined.
View Article and Find Full Text PDFChanges and associations between synovial fluid and magnetic resonance imaging markers of osteoarthritis after high tibial osteotomy.
Arthritis Res Ther
October 2024
Bone and Joint Institute, Western University, London, ON, Canada.
Article Synopsis
- - The study aimed to examine changes in knee joint health before and one year after high tibial osteotomy (HTO) surgery, specifically looking at synovial fluid biomarkers and MRI results for knee effusion-synovitis and cartilage health.
- - Results showed a decrease in inflammation markers related to Toll-like receptor and TNF-α signaling, with significant decreases in effusion-synovitis volume and specific biomarkers such as IL-6 and IL-1β linked to knee joint improvement over the year.
- - Additionally, the articular cartilage's composition, measured by T2 relaxation time, also improved after HTO surgery, with correlations found between this improvement and changes in several key growth factors and cytokines in the syn
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!